| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6009722 | Epilepsy & Behavior | 2016 | 10 Pages |
Abstract
The addition of a third ASD is a universally cost-effective treatment option in the management of children with drug-resistant epilepsy that has failed to improve with 2 ASDs. For children whose epilepsy has failed to improve with 3 ASDs, the most cost-effective treatment depends on the health-care resources available reflected by the WTP.
Keywords
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Aria Fallah, Alexander G. Weil, Shelly Wang, Evan Lewis, Christine B. Baca, Gary W. Mathern,